Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TLE1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | HSPB8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | YIF1A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | ATF4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PTGIS | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | STK32A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | WRAP53 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | HNRNPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ZNF143 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |